Alignment Healthcare LLC
$ 17.93
-1.75%
08 May - close price
- Market Cap 3,772,892,000 USD
- Current Price $ 17.93
- High / Low $ 18.35 / 17.27
- Stock P/E 182.50
- Book Value 1.00
- EPS 0.10
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.02 %
- ROE 0.12 %
- 52 Week High 23.87
- 52 Week Low 11.62
About
Alignment Healthcare, Inc. provides a consumer-centric platform that provides personalized healthcare to seniors in the United States. The company is headquartered in Orange, California.
Analyst Target Price
$25.54
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-30 | 2026-02-26 | 2025-10-30 | 2025-07-30 | 2025-04-30 | 2025-02-25 | 2024-10-29 | 2024-08-01 | 2024-05-02 | 2024-02-27 | 2023-11-02 | 2023-08-03 |
| Reported EPS | 0.1214 | -0.05 | 0.02 | 0.1382 | 0.0443 | -0.057 | -0.14 | -0.13 | -0.25 | -0.25 | -0.18 | -0.15 |
| Estimated EPS | 0.0121 | -0.16 | -0.08 | -0.0616 | -0.072 | -0.084 | -0.14 | -0.14 | -0.22 | -0.22 | -0.18 | -0.22 |
| Surprise | 0.1093 | 0.11 | 0.1 | 0.1998 | 0.1163 | 0.027 | 0 | 0.01 | -0.03 | -0.03 | 0 | 0.07 |
| Surprise Percentage | 903.3058% | 68.75% | 125% | 324.3506% | 161.5278% | 32.1429% | 0% | 7.1429% | -13.6364% | -13.6364% | 0% | 31.8182% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ALHC
2026-05-06 04:38:48
Alignment Healthcare (ALHC) shares dropped over 12% in mid-day trading, putting it on track for its largest single-day percentage decline since October 2024. The stock also saw a significant increase in trading volume, indicating strong investor reaction to the downturn.
2026-05-04 08:10:05
Alignment Healthcare (ALHC) reported a profitable first quarter with strong revenue and net income, exceeding expectations and raising full-year guidance. Despite recent share price volatility, the company shows strong long-term growth and is considered undervalued by analysts, trading at a discount to both the average analyst target and intrinsic value estimates. This valuation is supported by its technology-enabled care model, efforts to reduce SG&A, and expansion into new markets, although potential changes in Medicare Advantage policies and competition pose risks.
2026-05-03 15:10:22
Alignment Healthcare (ALHC) has achieved profitability on a trailing twelve-month (TTM) basis, reporting US$19.8m in profit for Q1 2026 after previous losses, with revenue reaching US$4.3b TTM. This milestone supports bullish views on earnings growth, though quarterly fluctuations highlight sensitivity to margins and costs. The stock trades at a P/S of about 1x, below its peer average and analyst targets, indicating potential value despite inherent risks in the healthcare sector.
2026-05-02 18:09:04
Alignment Healthcare (ALHC) recorded a significant turnaround in Q1 2026, achieving profitability with net income of US$11.42 million and raising its full-year revenue guidance to US$5.18 billion. This positive performance reinforces the company's tech-enabled Medicare Advantage model, suggesting improving scale and operating leverage, though investors are cautioned about potential regulatory changes. The strong results and a recent equity offering provide flexibility for continued investment, but investors should weigh these positives against potential policy shifts and existing analyst forecasts.
2026-05-02 08:06:00
Alignment Healthcare, Inc. (NASDAQ:ALHC) reported strong Q1 2026 results, exceeding guidance with 31% membership growth, 33% revenue growth, and an 88% increase in adjusted EBITDA. The company highlighted ongoing investments in automation and AI to improve efficiency and scalability, expressing confidence in achieving its long-term goal of 1 million members while adapting to Medicare Advantage policy changes.
2026-05-02 07:39:39
Barclays analyst Andrew Mok CFA maintained a Hold rating on Alignment Healthcare (ALHC) and set a price target of $19.00. The analyst consensus for ALHC is a Strong Buy with an average price target of $25.60, despite the company reporting a GAAP net loss of $11.01 million on quarterly revenue of $1.01 billion. Corporate insider sentiment for ALHC is negative, with an increase in insider selling.
